UBI / UNIVERSAL BIOSENSORS INC - Insider Trading and Ownership Report - SEC Form 3, 4, 5

UNIVERSAL BIOSENSORS INC
US ˙ NASDAQ
DIESES SYMBOL IST NICHT MEHR AKTIV

Insider-Aktien152.417.701 shares
Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

N/A

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

N/A

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

UNIVERSAL BIOSENSORS INC Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in UBI / UNIVERSAL BIOSENSORS INC getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Max
Preis bei
Max
Max
Gewinn ($)
Max Rendite (%)
2024-05-27 Coleman Craig E. 1.421.293 0,1100 1.421.293 0,1100 156.342 730
2024-05-01 Coleman Craig E. 217.182 0,1500 217.182 0,1500 32.577
2024-05-01 Coleman Craig E. 29.289.424 0,1500 29.289.424 0,1500 4.393.414
2024-03-25 Coleman Craig E. 1.000.000 0,2000 1.000.000 0,2000 200.000
2023-09-11 Coleman Craig E. 100.000 0,2200 100.000 0,2200 22.000
2023-06-30 Hoey David L 95.983 0,1679 95.983 0,1679 16.116
2022-11-16 Coleman Craig E. 17.848 0,2400 17.848 0,2400 4.284
2022-11-15 Coleman Craig E. 82.152 0,2400 82.152 0,2400 19.716
2022-11-11 Coleman Craig E. 50.000 0,2500 50.000 0,2500 12.500

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

UBI / UNIVERSAL BIOSENSORS INC Insider Trades
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in UBI / UNIVERSAL BIOSENSORS INC. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Min
Preis bei
Min
Max Verlust
Vermieden($)
Max Verlust
Vermieden(%)
2021-01-07 Coleman Craig E. 12.559.109 12.559.109 730
2020-07-07 CVC Ltd 23.820.765 0,2200 23.820.765 0,2200 5.240.568
2019-11-01 VF Strategic Equities Fund 3.439.866 0,1800 3.439.866 0,1800 619.176
2016-12-02 VF Australian Equities Fund 154.736 0,3200 154.736 0,3200 49.516
2015-12-16 Chambers Garry 100.000 0,4500 100.000 0,4500 45.000
2013-02-12 Oates Adrian 8.333 7.291,3800 8.333 7.291,3800 60.759.070
2012-05-16 DENVER ANDREW 676.153 378.645,6800 676.153 378.645,6800 256.022.412.469
2012-05-15 DENVER ANDREW 678.375 379.890,0000 678.375 379.890,0000 257.707.878.750

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

UBI / UNIVERSAL BIOSENSORS INC Insider Trades
Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei
Datum
Handel
Datum
Form Insider Ticker Wertpapier-Titel Code 10b5-1 Direkt Ausführung
Preis
Einheit
Preis
Eimheiten
Verändert
Wert
Geändert (1K)
Verbleibende
Optionen
Verbleibende
Aktien
2025-02-11 3 Mullin Peter George UBI Common Stock D 444.424
2025-02-11 3 Mullin Peter George Mullin Family Superannuation Fund UBI Common Stock I 1.519.261
2025-02-11 3 Mullin Peter George Mullin Family Trust UBI Common Stock I 577.000
2024-05-28 2024-05-27 4 Sharman John Stewart By wife UBI Common Stock A - Award I 0,1100 275.000 30 1.561.217
2024-05-28 2024-05-27 4 McLean Graham A UBI Common Stock A - Award I 0,1100 275.000 30 1.080.116
2024-05-28 2024-05-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1100 1.421.293 156 87.509.318
2024-05-03 2024-05-01 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,1500 217.182 33 970.802
2024-05-03 2024-05-01 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1500 29.289.424 4.393 86.088.025
2024-05-03 2024-05-01 4 McLean Graham A UBI Common Stock A - Award I 0,1500 180.116 27 805.116
2024-05-03 2024-05-01 4 Sharman John Stewart By superannuation fund UBI Common Stock A - Award I 0,1500 30.000 4 394.666
2024-05-03 2024-05-01 4 Sharman John Stewart UBI Common Stock A - Award D 0,1500 23.055 3 103.055
2024-05-03 2024-05-01 4 Sharman John Stewart By wife UBI Common Stock A - Award I 0,1500 10.000 2 1.286.217
2024-05-03 2024-05-01 4 Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary UBI Common Stock A - Award I 0,1500 99.077 15 442.873
2024-05-03 2024-03-25 4 Sharman John Stewart UBI Common Stock G - Gift D -1.000.000 80.000
2024-05-03 2024-03-25 4 Sharman John Stewart By wife UBI Common Stock G - Gift I 1.000.000 1.276.217
2024-03-26 2024-03-25 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2000 1.000.000 200 56.798.601
2024-03-25 2024-03-25 4 Sharman John Stewart UBI Common Stock M - Exercise D 0,2000 1.364.666 273 1.444.666
2023-12-11 2023-12-11 4 McLean Graham A Stock acquired by Milray Enterprises Pty Ltd ATF Graham McLean Family Trust UBI Common Stock A - Award I 0,1987 75.000 15 625.000
2023-09-13 2023-09-11 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,2200 100.000 22 753.620
2023-08-21 2023-06-30 4 Hoey David L UBI Common Stock P - Purchase D 0,1679 95.983 16 662.397
2023-03-15 2023-03-14 4 McLean Graham A UBI Common Stock A - Award I 0,2500 150.000 38 550.000
2023-01-03 2023-01-01 4 Balak Salesh UBI Common Stock A - Award D 50.000 388.558
2023-01-03 2023-01-01 4 Sharman John Stewart UBI Common Stock A - Award D 50.000 80.000
2022-12-13 2022-12-12 4 McLean Graham A UBI Common Stock A - Award I 0,2300 200.000 46 400.000
2022-11-16 2022-11-16 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,2400 17.848 4 653.620
2022-11-16 2022-11-15 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,2400 82.152 20 635.772
2022-11-16 2022-11-11 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,2500 50.000 12 553.620
2022-08-18 2022-08-17 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,2800 200.000 56 503.620
2022-06-21 2022-05-27 4 Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary UBI Common Stock A - Award I 0,7700 43.796 34 343.796
2022-06-15 2022-06-09 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,3800 25.000 10 303.620
2022-06-01 2022-06-01 4 McLean Graham A UBI Common Stock A - Award I 0,4600 96.613 44 200.000
2022-06-01 2022-05-31 4 McLean Graham A UBI Common Stock A - Award I 0,4600 3.387 2 103.387
2022-05-31 2022-05-27 4 Coleman Craig E. By Partnership UBI Stock Option (Right to Buy - Exercise Price $1.00) P - Purchase I 1.920.000 1.920.000
2022-05-31 2022-05-27 4 Coleman Craig E. By Partnership UBI Stock Option (Right to Buy - Exercise Price $0.92) P - Purchase I 1.920.000 1.920.000
2022-05-31 2022-05-27 4 Coleman Craig E. By Partnership UBI Stock Option (Right to Buy - Exercise Price $0.20) P - Purchase I 0,5700 1.000.000 570 1.000.000
2022-05-31 2022-05-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,4350 1.280.000 557 55.798.601
2022-05-31 2022-05-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,7700 25.893.617 19.938 54.518.601
2022-05-31 2022-05-27 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,7700 10.000 8 278.620
2022-05-31 2022-05-24 4 Coleman Craig E. By the Coleman Super Fund UBI Common Stock P - Purchase I 0,4800 48.620 23 268.620
2022-05-31 2022-05-27 4 Sharman John Stewart By wife UBI Stock Option (Right to Buy) S - Sale I 0,20 0,5700 -1.000.000 -570 0
2022-05-27 2022-05-27 4 Balak Salesh UBI Common Stock A - Award D 0,7700 2.000 2 338.558
2022-05-13 2022-05-12 4 McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member UBI Common Stock A - Award I 0,5000 64.962 32 100.000
2022-05-13 2022-05-11 4 McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member UBI Common Stock A - Award I 0,5000 35.038 18 35.038
2022-02-28 2022-02-24 4 Balak Salesh UBI Common Stock A - Award D 30.000 336.558
2022-02-28 2022-02-24 4 Sharman John Stewart UBI Common Stock A - Award D 30.000 30.000
2021-11-05 2021-11-05 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,7490 329.613 247 28.624.984
2021-11-05 2021-11-03 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,7490 152.638 114 28.295.371
2021-11-05 2021-11-01 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,7300 896.506 654 28.142.733
2021-09-14 2021-08-19 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -40.000 0
2021-09-14 2021-08-19 4 Balak Salesh UBI Performance Rights A - Award D 250.000 250.000
2021-09-14 2021-08-19 4 Balak Salesh UBI Performance Rights A - Award D 500.000 500.000
2021-09-14 2021-08-19 4 Balak Salesh UBI Common Stock M - Exercise D 40.000 306.558
2021-09-14 2021-08-19 4 Sharman John Stewart UBI Performance Rights A - Award D 1.250.000 1.250.000
2021-09-14 2021-08-19 4 Sharman John Stewart UBI Performance Rights A - Award D 2.500.000 2.500.000
2021-09-14 2020-03-24 4 Sharman John Stewart By wife UBI Stock Option (Right to Buy) G - Gift I 0,20 1.000.000 1.000.000
2021-09-14 2020-03-24 4 Sharman John Stewart UBI Stock Option (Right to Buy) G - Gift D 0,20 -1.000.000 1.364.666
2021-01-11 2021-01-07 4 Coleman Craig E. By Partnership UBI Common Stock S - Sale I -12.559.109 27.246.227
2020-12-23 2020-12-11 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -40.000 0
2020-12-23 2020-12-11 4 Balak Salesh UBI Common Stock M - Exercise D 40.000 266.558
2020-11-03 2020-11-02 4 Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary UBI Common Stock A - Award I 0,3100 200.000 62 300.000
2020-09-15 2020-09-15 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3400 784.687 267 39.805.336
2020-09-15 2020-09-14 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3300 80.178 26 39.020.649
2020-09-15 2020-09-10 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3250 135.135 44 38.940.471
2020-09-09 2020-09-01 4 Balak Salesh UBI Stock Option (Right to Buy) A - Award D 0,30 500.000 500.000
2020-09-08 2020-09-07 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3250 322.315 105 38.805.336
2020-09-08 2020-09-04 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3040 284.962 87 38.483.021
2020-09-08 2020-09-03 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3210 100.000 32 38.198.059
2020-07-30 2020-07-27 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2500 730.999 183 12.559.109
2020-07-30 2020-07-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2500 1.461.998 365 38.098.059
2020-07-09 2020-07-07 4 CVC Ltd UBI Common Stock S - Sale D 0,2200 -23.820.765 -5.241 0
2020-06-08 3 Sharman John Stewart By wife UBI Common Stock I 552.434
2020-06-08 3 Sharman John Stewart By wife UBI Common Stock I 552.434
2020-06-08 3 Sharman John Stewart By wife UBI Common Stock I 552.434
2019-12-02 2019-12-02 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2000 119.519 24 36.636.061
2019-12-02 2019-11-28 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2000 1.885.217 377 36.516.542
2019-12-02 2019-11-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1910 214.783 41 34.631.325
2019-11-25 2019-11-12 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -25.000 0
2019-11-25 2019-11-12 4 Balak Salesh UBI Common Stock M - Exercise D 25.000 226.558
2019-11-18 2019-11-15 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1900 36.500 7 34.416.542
2019-11-18 2019-11-13 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1860 669.597 125 34.380.042
2019-11-18 2019-11-01 4 VF Strategic Equities Fund UBI Common Stock S - Sale D 0,1800 -3.439.866 -619 18.442.469
2019-09-12 2019-09-12 4 VF Strategic Equities Fund UBI Common Stock P - Purchase D 0,1900 80.000 15 21.882.335
2019-09-12 2019-09-11 4 VF Strategic Equities Fund UBI Common Stock P - Purchase D 0,1900 1.710.683 325 21.802.335
2019-09-12 2019-09-12 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1900 80.000 15 33.710.445
2019-09-12 2019-09-11 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,1900 1.710.683 325 33.630.445
2019-07-09 2019-05-29 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -73.334 0
2019-07-09 2019-05-29 4 Balak Salesh UBI Common Stock M - Exercise D 73.334 201.558
2019-03-06 2019-02-28 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -105.000 0
2019-03-06 2019-02-28 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -25.000 0
2019-03-06 2019-02-28 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -40.000 0
2019-03-06 2019-02-28 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -40.000 0
2019-03-06 2019-02-28 4 Oates Adrian UBI Common Stock M - Exercise D 40.000 291.837
2019-03-06 2019-02-28 4 Oates Adrian UBI Common Stock M - Exercise D 40.000 291.837
2019-03-06 2019-02-28 4 Oates Adrian UBI Common Stock M - Exercise D 25.000 211.837
2019-03-06 2019-02-28 4 Oates Adrian UBI Common Stock M - Exercise D 105.000 186.837
2019-03-06 2019-03-05 4 CVC Ltd UBI Common Stock P - Purchase D 0,2100 176.151 37 23.820.765
2019-03-05 2019-03-01 4 CVC Ltd UBI Common Stock P - Purchase D 0,2100 100.000 21 23.644.614
2019-01-14 2018-12-14 4 Balak Salesh UBI Common Stock A - Award D 4.166 128.224
2019-01-14 2018-11-16 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -25.000 0
2019-01-14 2018-11-16 4 Balak Salesh UBI Common Stock M - Exercise D 25.000 124.058
2019-01-14 2018-11-16 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -25.000 0
2019-01-14 2018-11-16 4 Oates Adrian UBI Common Stock M - Exercise D 25.000 81.837
2019-01-14 2018-12-14 4 Legleiter Rick L UBI Common Stock A - Award D 4.166 162.853
2018-12-06 2018-12-04 4 CVC Ltd UBI Common Stock P - Purchase D 0,2100 1.500.000 315 23.544.614
2018-11-05 3 CVC Ltd UBI Common Stock D 43.889.228
2018-11-05 3 CVC Ltd UBI Common Stock D 43.889.228
2018-11-05 3 CVC Ltd UBI Common Stock D 43.889.228
2018-11-05 2018-10-11 4 CVC Ltd UBI Common Stock P - Purchase D 0,2300 100.000 23 22.044.614
2018-05-11 2018-05-09 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2400 66.584 16 31.915.182
2018-05-11 2018-05-09 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2400 66.584 16 11.823.530
2018-05-08 2018-05-04 4 Legleiter Rick L UBI Common Stock P - Purchase D 0,2585 158.687 41 158.687
2018-05-07 2018-05-07 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2320 198.640 46 31.848.598
2018-05-07 2018-05-03 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2280 124.305 28 31.649.958
2018-05-07 2018-05-07 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2320 198.640 46 11.756.946
2018-05-07 2018-05-03 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2280 124.305 28 11.558.306
2018-03-19 2018-03-15 4 Hoey David L UBI Common Stock P - Purchase D 0,2051 100.000 21 566.414
2018-02-05 2018-02-01 4 Hoey David L UBI Common Stock P - Purchase D 0,2300 116.414 27 466.414
2017-12-29 2017-12-29 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3000 750.318 225 11.434.001
2017-12-29 2017-12-28 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2940 50.374 15 10.683.683
2017-12-29 2017-12-27 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2890 56.245 16 10.633.309
2017-12-29 2017-12-22 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,2690 33.613 9 10.577.064
2017-12-29 2017-12-29 4 VF Strategic Equities Fund UBI Common Stock P - Purchase D 0,3000 2.250.953 675 20.091.652
2017-12-29 2017-12-28 4 VF Strategic Equities Fund UBI Common Stock P - Purchase D 0,2940 151.124 44 17.840.699
2017-12-29 2017-12-27 4 VF Strategic Equities Fund UBI Common Stock P - Purchase D 0,2890 168.737 49 17.689.575
2017-12-29 2017-12-22 4 VF Strategic Equities Fund UBI Common Stock P - Purchase D 0,2690 100.838 27 17.520.838
2017-12-29 2017-12-29 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3000 3.001.271 900 31.525.653
2017-12-29 2017-12-28 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2940 201.498 59 28.524.382
2017-12-29 2017-12-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2890 224.982 65 28.322.884
2017-12-29 2017-12-22 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,2690 134.451 36 28.097.902
2017-10-26 2017-10-24 4 Legleiter Rick L UBI Stock Option (Right to Buy) A - Award D 0,80 3.300.000 3.300.000
2017-10-26 2017-10-24 4 Legleiter Rick L UBI Stock Option (Right to Buy) A - Award D 0,60 2.700.000 2.700.000
2017-10-26 2017-10-24 4 Legleiter Rick L UBI Stock Option (Right to Buy) A - Award D 0,50 1.600.000 1.600.000
2017-10-26 2017-10-24 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -16.667 0
2017-10-26 2017-10-24 4 Balak Salesh UBI Common Stock M - Exercise D 16.667 99.058
2017-10-26 2017-10-24 4 Chambers Garry UBI Stock Option (Right to Buy M - Exercise D 0,00 -25.000 0
2017-10-26 2017-10-24 4 Chambers Garry UBI Common Stock M - Exercise D 25.000 2.275.594
2017-10-26 2017-10-24 4 Hodges Alastair UBI Stock Option (Right to Buy) M - Exercise D 0,00 -25.000 0
2017-10-26 2017-10-24 4 Hodges Alastair UBI Common Stock M - Exercise D 25.000 2.871.615
2017-08-17 2017-08-16 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -16.667 0
2017-08-17 2017-08-16 4 Oates Adrian UBI Stock Option (Right to Buy) M - Exercise D 0,00 -25.000 0
2017-08-17 2017-08-16 4 Oates Adrian UBI Common Stock M - Exercise D 41.667 56.837
2017-03-27 2016-12-28 4 Hodges Alastair UBI Restricted Shares of Common Stock A - Award D 3.030 2.846.615
2017-03-27 2016-12-28 4 Oates Adrian UBI Restricted Shares of Common Stock A - Award D 3.030 15.170
2017-03-27 2016-12-28 4 Chambers Garry UBI Restricted Shares of Common Stock A - Award D 3.030 2.250.594
2017-03-27 2016-12-28 4 Balak Salesh UBI Restricted Shares of Common Stock A - Award D 3.030 82.391
2017-03-01 2017-03-01 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3800 32.988 13 10.543.451
2017-03-01 2017-02-28 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3850 247.001 95 10.510.463
2017-03-01 2017-02-27 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3820 402.924 154 10.263.462
2017-03-01 2017-03-01 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3800 32.988 13 27.963.451
2017-03-01 2017-02-28 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3850 247.001 95 27.930.463
2017-03-01 2017-02-27 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3820 402.924 154 27.683.462
2017-02-17 2017-02-17 4 Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary UBI Common Stock A - Award I 0,3650 65.000 24 100.000
2017-02-17 2017-02-14 4 Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary UBI Common Stock A - Award I 0,3350 35.000 12 35.000
2017-02-16 2017-02-14 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3400 7.782 3 9.860.538
2017-02-16 2017-02-14 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3400 7.782 3 27.280.538
2017-01-03 2016-12-29 4 Hodges Alastair UBI Restricted Shares of Common Stock A - Award D 3.030 2.846.615
2017-01-03 2016-12-29 4 Balak Salesh UBI Restricted Shares of Common Stock A - Award D 3.030 82.391
2017-01-03 2016-12-29 4 Chambers Garry UBI Restricted Shares of Common Stock A - Award D 3.030 2.250.594
2017-01-03 2016-12-29 4 Oates Adrian UBI Restricted Shares of Common Stock A - Award D 3.030 15.170
2016-12-08 2016-12-06 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3347 16.078 5 27.272.756
2016-12-08 2016-12-06 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3347 16.078 5 9.852.756
2016-12-05 2016-12-05 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3282 112.009 37 27.256.678
2016-12-05 2016-12-02 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3200 165.000 53 27.144.669
2016-12-05 2016-12-01 4 Coleman Craig E. By Partnership UBI Common Stock P - Purchase I 0,3196 1.807.004 578 26.979.669
2016-12-05 2016-12-02 4 VF Australian Equities Fund UBI Common Stock S - Sale D 0,3200 -154.736 -50 0
2016-12-05 2016-12-05 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3282 112.009 37 9.836.678
2016-12-05 2016-12-02 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3200 154.736 50 9.724.669
2016-12-05 2016-12-02 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3200 165.000 53 9.569.933
2016-12-05 2016-12-01 4 VF High Conviction Fund UBI Common Stock P - Purchase D 0,3196 1.807.004 578 9.404.933
2016-09-30 2016-09-28 4 Hoey David L UBI Common Stock P - Purchase D 0,2900 150.000 44 350.000
2016-07-20 3 VF Australian Equities Fund UBI Common Stock D 309.472
2016-07-20 3 VF Australian Equities Fund UBI Common Stock D 309.472
2016-07-20 3 VF High Conviction Fund UBI Common Stock D 15.195.858
2016-07-20 3 VF High Conviction Fund UBI Common Stock D 15.195.858
2016-07-20 3 VF Strategic Equities Fund UBI Common Stock D 34.840.000
2016-07-20 3 VF Strategic Equities Fund UBI Common Stock D 34.840.000
2016-07-11 3 Coleman Craig E. By the Coleman Super Fund UBI Common stock, par value US$0.0001 I 25.612.665
2016-07-11 3 Coleman Craig E. By partnership UBI Common stock, par value US$0.0001 I 50.565.330
2016-07-11 3 Coleman Craig E. By the Coleman Super Fund UBI Common stock, par value US$0.0001 I 25.612.665
2016-07-11 3 Coleman Craig E. By partnership UBI Common stock, par value US$0.0001 I 50.565.330
2016-06-14 2016-06-10 4 Hoey David L UBI Common Stock P - Purchase D 0,2900 200.000 58 200.000
2016-02-26 2016-02-17 4 Balak Salesh UBI Common Stock A - Award D 2.500 79.361
2016-02-26 2016-02-17 4 Oates Adrian UBI Common Stock A - Award D 2.500 12.140
2016-02-25 2016-02-17 4 Hodges Alastair UBI Common stock A - Award D 2.500 2.843.585
2016-02-19 2016-02-17 4 Chambers Garry UBI Common stock A - Award D 2.500 2.247.564
2016-02-19 2015-12-16 4 Chambers Garry UBI Common stock S - Sale D 0,4500 -100.000 -45 2.245.064
2016-01-14 2015-12-31 4 Hodges Alastair UBI Stock Option (Right to Buy) M - Exercise D 0,26 -36.248 0
2016-01-14 2015-12-31 4 Hodges Alastair UBI Common Stock M - Exercise D 0,2600 36.248 9 2.841.085
2016-01-14 2015-12-18 4 Hodges Alastair UBI Common stock D - Sale to Issuer D 0,4600 -30.000 -14 2.804.837
2015-07-13 2015-07-09 4 Wright Paul UBI Stock Option (Right to Buy) A - Award D 0,00 60.000 60.000
2015-07-13 2015-07-09 4 Wright Paul UBI Common stock A - Award D 4.347 7.304
2015-03-02 2015-02-20 4/A Wright Paul By Chatsworth Trust UBI Common stock P - Purchase I 101.819,8200 337.428 34.356.858 337.428
2015-03-02 2015-02-26 4 Wright Paul By Chatsworth Trust UBI Common stock P - Purchase I 99.812,5700 269.088 26.858.365 606.516
2015-02-24 2015-02-20 4 Wright Paul By Chatsworth Trust UBI Common stock A - Award I 101.819,8200 337.428 34.356.858 337.428
2015-02-03 2015-01-30 4 Hodges Alastair UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2015-02-03 2015-01-30 4 Hodges Alastair UBI Common Stock A - Award D 4.347 2.834.837
2015-02-03 2015-01-30 4 Chambers Garry UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2015-02-03 2015-01-30 4 Chambers Garry UBI Common Stock A - Award D 4.347 2.345.064
2015-02-03 2015-01-30 4 Oates Adrian UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2015-02-03 2015-01-30 4 Oates Adrian UBI Common Stock A - Award D 4.347 9.640
2015-02-03 2015-01-30 4 Balak Salesh UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2015-02-03 2015-01-30 4 Balak Salesh UBI Common Stock A - Award D 4.347 76.861
2014-06-13 2014-06-12 4 Wright Paul UBI Common stock A - Award D 2.040 2.957
2014-06-13 2013-12-12 4 Wright Paul UBI Stock Option (Right to Buy) A - Award D 0,00 60.000 60.000
2014-05-16 2014-05-15 4 DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver UBI Common Stock P - Purchase I 7.670,0000 50.000 383.500 2.886.340
2014-05-16 2014-05-14 4 DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver UBI Common Stock P - Purchase I 8.940,0000 50.000 447.000 2.836.340
2014-05-14 2014-05-14 4 Hanley Denis UBI Common Stock P - Purchase D 8.127,9000 50.000 406.395 1.918.002
2014-05-13 2014-05-13 4 DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver UBI Common Stock P - Purchase I 11.500,0000 50.000 575.000 2.786.340
2014-05-13 2014-05-12 4 DENVER ANDREW By wife UBI Common Stock P - Purchase I 6.610,5000 30.000 198.315 90.797
2014-05-08 2014-05-06 4 Smith Christopher M UBI Common Stock P - Purchase D 11.249,9500 30.000 337.498 30.000
2014-04-16 2014-04-14 4 Wright Paul By Macquarie Super Manager UBI Common Stock A - Award I 56.567,0800 142.105 8.038.465 186.771
2014-01-08 2013-12-12 4 Davis Frederick Harry UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2014-01-08 2013-12-12 4 Davis Frederick Harry UBI Common Stock A - Award D 2.040 2.957
2014-01-06 2013-12-24 4 Hodges Alastair UBI Stock Option (Right to Buy) M - Exercise D 0,22 -384.224 0
2014-01-06 2013-12-24 4 Hodges Alastair UBI Common Stock M - Exercise D 0,2200 384.224 85 2.830.490
2014-01-06 2013-12-12 4 Hodges Alastair UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2014-01-06 2013-12-12 4 Hodges Alastair UBI Common Stock A - Award D 2.040 2.446.266
2014-01-06 2013-12-12 4 Balak Salesh UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2014-01-06 2013-12-12 4 Balak Salesh UBI Common Stock A - Award D 2.040 72.514
2014-01-06 2013-12-24 4 Chambers Garry UBI Stock Option (Right to Buy) M - Exercise D 0,22 -288.168 0
2014-01-06 2013-12-24 4 Chambers Garry UBI Common Stock M - Exercise D 0,2200 288.168 63 2.340.717
2014-01-06 2013-12-12 4 Chambers Garry UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2014-01-06 2013-12-12 4 Chambers Garry UBI Common Stock A - Award D 2.040 2.052.549
2014-01-06 2013-12-12 4 Oates Adrian UBI Stock Option (Right to Buy) A - Award D 0,00 40.000 40.000
2014-01-06 2013-12-12 4 Oates Adrian UBI Common Stock A - Award D 2.040 5.293
2013-10-09 2013-09-26 4 Heinberg Marshall UBI Common Stock J - Other D 20.000 20.000
2013-10-04 2013-09-26 4 DENVER ANDREW By Andrew Denver & Linda Denver & Allison Denver UBI Common Stock J - Other I 200.000 2.736.340
2013-10-04 2013-09-26 4 DENVER ANDREW UBI Common Stock J - Other D 28.000 437.050
2013-10-04 2013-09-26 4 Hanley Denis Denis Hanley Superannuation Fund Pty Ltd UBI Common Stock J - Other I 200.000 954.105
2013-10-04 2013-09-26 4 Hanley Denis Denis M Hanley Pty Ltd UBI Common Stock J - Other I 6.000 54.889
2013-10-04 2013-09-26 4 Hanley Denis UBI Common Stock J - Other D 29.772 1.868.002
2013-06-11 2013-06-11 4 Hodges Alastair UBI Stock Option (Right to Buy) M - Exercise D 0,22 -384.224 384.224
2013-06-11 2013-06-11 4 Hodges Alastair UBI Common Stock M - Exercise D 84.529,2800 384.224 32.478.178 2.444.226
2013-06-11 2013-06-11 4 Chambers Garry UBI Stock Option (Right to Buy) M - Exercise D 0,22 -288.168 288.168
2013-06-11 2013-06-11 4 Chambers Garry UBI Common Stock M - Exercise D 63.396,9600 288.168 18.268.975 2.050.509
2013-05-28 2013-05-27 4 Wright Paul UBI Common Stock A - Award D 917 917
2013-05-28 2012-11-13 4 Wright Paul UBI Stock Option (Right to Buy) A - Award D 0,00 37.500 37.500
2013-02-20 2013-02-12 4 Oates Adrian UBI Common Stock S - Sale D 7.291,3800 -8.333 -60.759 3.253
2013-01-08 2012-05-16 4 DENVER ANDREW UBI Common Stock P - Purchase I 378.645,6800 676.153 256.022.412 2.536.340
2013-01-08 2012-05-16 4 DENVER ANDREW By spouse UBI Common Stock S - Sale I 378.645,6800 -676.153 -256.022.412 60.797
2013-01-08 2012-05-15 4 DENVER ANDREW UBI Common Stock P - Purchase I 379.890,0000 678.375 257.707.879 1.860.187
2013-01-08 2012-05-15 4 DENVER ANDREW UBI Common Stock S - Sale D 379.890,0000 -678.375 -257.707.879 409.050
2012-12-28 2012-12-18 4 Wilson Elizabeth UBI Common Stock J - Other I 3.999,6000 4.444 17.774 2.035.944
2012-12-28 2012-12-19 4 Balak Salesh UBI Common Stock J - Other D 1.999,8000 2.222 4.444 70.474
2012-12-28 2012-12-18 4 Wright Paul By Macquarie Super Manager UBI Common Stock J - Other I 14.999,4000 16.666 249.980 44.666
2012-11-23 2012-11-13 4 Hodges Alastair UBI Stock Option (Right to Buy) A - Award D 0,00 25.000 25.000
2012-11-23 2012-11-13 4 Hodges Alastair UBI Common Stock A - Award D 917 2.060.002
2012-11-23 2012-11-13 4 Oates Adrian UBI Stock Option (Right to Buy) A - Award D 0,00 25.000 25.000
2012-11-23 2012-11-13 4 Oates Adrian UBI Common Stock A - Award D 917 11.586
2012-11-23 2012-11-13 4 Davis Frederick Harry UBI Stock Option (Right to Buy) A - Award D 0,00 25.000 25.000
2012-11-23 2012-11-13 4 Davis Frederick Harry UBI Common Stock A - Award D 917 917
2012-11-21 2012-11-13 4 Balak Salesh UBI Stock Option (Right to Buy) A - Award D 0,00 25.000 25.000
2012-11-21 2012-11-13 4 Balak Salesh UBI Common Stock A - Award D 917 68.252
2012-11-21 2012-11-13 4 Chambers Garry UBI Stock Option (Right to Buy) A - Award D 0,00 25.000 25.000
2012-11-21 2012-11-13 4 Chambers Garry UBI Common Stock A - Award D 917 1.762.341
2012-08-27 2012-08-27 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -8.333 0
2012-08-27 2012-08-27 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -8.333 0
2012-08-27 2012-08-27 4 Balak Salesh UBI Stock Option (Right to Buy) M - Exercise D 0,00 -21.666 73.334
2012-08-27 2012-08-27 4 Balak Salesh UBI Common Stock M - Exercise D 38.332 67.335
2012-08-27 2012-08-23 4 Davis Frederick Harry By wife UBI Common Stock P - Purchase I 0,7000 23.376 16 28.747
2012-08-27 2012-08-22 4 Davis Frederick Harry By wife UBI Common Stock P - Purchase I 0,7000 5.371 4 5.371
2012-03-06 2012-02-27 4 Hodges Alastair UBI Common Stock S - Sale D 0,7300 -1.000.000 -730 2.059.085
2012-01-24 2011-03-07 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -25.000 -36 17.431.617
2012-01-24 2011-03-04 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -24.000 -34 17.456.617
2012-01-24 2011-03-03 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -10.000 -14 17.480.617
2012-01-24 2011-03-01 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -34 -0 17.490.617
2012-01-24 2011-02-28 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -1.083 -2 17.490.651
2012-01-24 2011-02-25 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -2.590 -4 17.491.734
2012-01-24 2011-02-23 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5200 -37.279 -57 17.494.324
2012-01-24 2011-02-18 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3600 -5.000 -7 17.531.603
2012-01-24 2011-02-17 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3500 -5.000 -7 17.536.603
2012-01-24 2011-02-16 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3600 -5.000 -7 17.541.603
2012-01-24 2011-02-15 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3600 -5.000 -7 17.546.603
2012-01-24 2011-02-11 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3800 -22.463 -31 17.551.603
2012-01-24 2011-02-09 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3600 -22 -0 17.574.066
2012-01-24 2011-02-08 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3700 -10.000 -14 17.574.088
2012-01-24 2011-02-07 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3800 -50.000 -69 17.584.088
2012-01-24 2011-02-02 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5300 -50.000 -76 17.589.088
2012-01-24 2011-02-01 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5200 -50.000 -76 17.639.088
2012-01-24 2011-01-31 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5000 -50.000 -75 17.689.088
2012-01-24 2011-01-28 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5200 -50.000 -76 17.739.088
2012-01-24 2011-01-27 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5100 -17.869 -27 17.789.088
2012-01-24 2011-01-25 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5200 -73 -0 17.806.957
2012-01-24 2011-01-24 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5100 -50.000 -76 17.807.030
2012-01-24 2011-01-21 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5100 -50.000 -76 17.857.030
2012-01-24 2011-01-20 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5100 -50.000 -76 17.907.030
2012-01-24 2011-01-19 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5200 -50.000 -76 17.957.030
2012-01-24 2011-01-18 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5100 -50.000 -76 18.007.030
2012-01-24 2011-01-14 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4800 -50.000 -74 18.057.030
2012-01-24 2011-01-13 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5000 -50.000 -75 18.107.038
2012-01-24 2011-01-12 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4900 -50.000 -74 18.157.030
2012-01-24 2011-09-08 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 0,9600 -1.500.000 -1.440 15.749.937
2012-01-24 2011-08-01 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,1900 -752 -1 17.249.937
2012-01-24 2011-07-28 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3000 -341 -0 17.250.689
2012-01-24 2011-04-29 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5300 -10.000 -15 17.251.030
2012-01-24 2011-04-28 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5200 -10.000 -15 17.261.030
2012-01-24 2011-04-27 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,5100 -10.000 -15 17.271.030
2012-01-24 2011-04-21 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4900 -35.000 -52 17.281.030
2012-01-24 2011-04-20 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4400 -10.000 -14 17.316.030
2012-01-24 2011-04-18 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -8.000 -11 17.326.030
2012-01-24 2011-04-15 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -7.500 -11 17.334.030
2012-01-24 2011-04-14 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4100 -10.000 -14 17.341.530
2012-01-24 2011-03-30 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3900 -155 -0 17.351.530
2012-01-24 2011-03-29 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3800 -32 -0 17.351.685
2012-01-24 2011-03-21 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,3600 -4.900 -7 17.351.717
2012-01-24 2011-03-10 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4000 -25.000 -35 17.356.617
2012-01-24 2011-03-09 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4200 -25.000 -36 17.381.617
2012-01-24 2011-03-08 5 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation UBI Common Stock S - Sale I 1,4100 -25.000 -35 17.406.617
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista